Cell-free infectivity of HIV type 1 produced in nonpermissive cells is only moderately impacted by C-terminal Env truncation despite abrogation of viral spread

AIDS Research and Human Retroviruses

Volumn 23, Issue 5, 2007, Pages 729-740

  Holtkotte, Denise ^a   Pfeiffer, Tanya ^a   Bosch, Valerie ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; MONOCLONAL ANTIBODY; SAQUINAVIR; VIRUS ENVELOPE PROTEIN; ZIDOVUDINE;

ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRION; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS TRANSMISSION;

CELL LINE; FLOW CYTOMETRY; GENE DELETION; GENE PRODUCTS, ENV; GENES, ENV; HIV-1; HUMANS; MUTATION; T-LYMPHOCYTES; TRANSFECTION; VIRUS REPLICATION;

EID: 34249899164     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0260     Document Type: Article

References (36)

1. Haffar OK. Dowbenko DJ. and Berman PW: The cytoplasmic tail of HIV-1 gp160 contains regions that associate with cellular membranes. Virology 1991;180:439-441.
2. Chernomordik L. Chanturiya AN, Suss-Toby E. Nora E, and Zimmerberg J: An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes. J Virol 1994;68:7115-7123.
3. Kliger Y and Shai Y: A leucine zipper-like sequence from the cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers. Biochemistry 1997;36:5157-5169.
4. Ohno H, Aguilar RC. Fournier MC, Hennecke S. Cosson P, and Bonifacino JS: Interaction of endocytic signals from the HIV-1 envelope glycoprotein complex with members of the adaptor medium chain family. Virology 1997;238:305-315.
5. Ohno H. Stewart J, Fournier MC, et al.: Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science 1995;269:1872-1875.
6. Murakami T and Freed EO: Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail. J Virol 2000;74:3548-3554.
7. Freed EO and Martin MA: Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J Virol 1996;70:341-351.
8. Cosson P: Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J 1996;15:5783-5788.
9. Wyma DJ, Kotov A. and Aiken C: Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles. J Virol 2000:74:9381-9387.
10. Lodge R. Lalonde JP, Lemay G, and Cohen EA: The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells. EMBO J 1997;16:695-705.
11. Lodge R. Gottlinger H, Gabuzda D, Cohen EA, and Lemay G: The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J Virol 1994:68:4857-4861.
12. Murakami T, Ablan S, Freed EO. and Tanaka Y: Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity. J Virol 2004;78:1026-1031.
13. Wyma DJ. Jiang J. Shi J, et al.: Coupling of human immunodeficiency virus type 1 fusion to virion maturation: A novel role of the gp41 cytoplasmic tail. J Virol 2004;78:3429-3435.
14. Dubay JW. Roberts SJ. Harm BH, and Hunter E: Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J Virol 1992:66:6616-6625.
15. Freed EO and Martin MA: Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J Virol 1995;69:1984-1989.
16. Gabuzda DH, Lever A. Terwilliger E, and Sodroski J: Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins. J Virol 1992:66:3306-3315.
17. Yu X, Yuan X, McLane MF, Lee TH, and Essex M: Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions. J Virol 1993;67:213-221.
18. Wilk T, Pfeiffer T, and Bosch V: Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology 1992;189:167-177.
19. Akari H. Fukumori T, and Adachi A: Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virions. J Virol 2000;74:4891-4893.
20. Murakami T and Freed EO: The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions. Proc Natl Acad Sci USA 2000;97:343-348.
21. Holtkotte D. Pfeiffer T, Pisch T. and Bosch V: Selection and characterization of a replication-competent human immunodeficiency virus type 1 variant encoding C-terminally truncated env. AIDS Res Hum Retroviruses 2006:22:57-65.
22. Bosch V and Pawlita M: Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site. J Virol 1990;64:2337-2344.
23. Pfeiffer T, Pisch T, Devitt G, Holtkotte D, and Bosch V: Effects of signal peptide exchange on HIV-1 glycoprotein expression and viral infectivity in mammalian cells. FEBS Lett 2006;580:3775-3778.
24. Freed EO, Myers DJ, and Risser R: Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc Natl Acad Sci USA 1990;87:4650-4654.
25. Naldini L, Blomer U, Gallay P, et al.: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996;272:263-267.
26. Derdeyn CA, Decker JM, Sfakianos JN, et al.: Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol 2000;74:8358-8367.
27. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, and Kabat D: Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 1998;72:2855-2864.
28. Wei X, Decker JM, Liu H, et al.: Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 2002;46:1896-1905.
29. Northrop JP, Ullman KS, and Crabtree GR: Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. J Biol Chem 1993;268:2917-2923.
30. Abacioglu YH, Fouts TR, Laman JD, et al.: Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res Hum Retroviruses 1994;10:371-381.
31. Chesebro B, Wehrly K, Nishio J, and Perryman S: Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism. J Virol 1992;66:6547-6554.
32. McCallus DE, Ugen KE, Sato AI, Williams WV, and Weiner DB: Construction of a recombinant bacterial human CD4 expression system producing a bioactive CD4 molecule. Viral Immunol 1992;5:163-172.
33. Davis MR, Jiang J, Zhou J, Freed EO, and Aiken C: A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41. J Virol 2006;80:2405-2417.
34. Sato H, Orenstein J, Dimitrov D, and Martin M: Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology 1992;186:712-724.
35. Jolly C, Kashefi K, Hollinshead M, and Sattentau QJ: HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med 2004;199:283-293.
36. Jolly C and Sattentau QJ: Retroviral spread by induction of virological synapses. Traffic 2004;5:643-650.